Data show our drug outperform other drugs on market so why want to share multi billion $ revenue stream with others if we can go all the way to commercialization alone and we r just 1 trial away. Gutsy move but if ANP can pull this off, man the amount of wealth to shareholders is unimaginable.
See how market react on Monday but long term ANP is starting a very special journey for shareholders and stakeholders in the next 12-18 months.
Headache now is where to get $$ to participate in the SPP.
$36.8m raise, page-15
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
-0.003(3.70%) |
Mkt cap ! $82.67M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.1¢ | 7.8¢ | $215.5K | 2.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 137820 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 319232 | 3 |
View Market Depth
| Last trade - 15.59pm 19/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |